Stock Market Status In our August 11 article Potential Pivots Upcoming for Stocks and Gold, we noted several legs that could be kicked out from under the S&P 500’s table in Q4 2017. The stock market blew right through one
October 13, 2017
Rembrandt Old man with a beard 1630 “The Cost of Missing the Market Boom is Skyrocketing”, says a Bloomberg headline today. That must be the scariest headline I’ve seen in quite a while. For starters, it’s misleading, because people who ‘missed’ the
I’ve blogged on some of the themes I’m going to cover below, but the story gets clearer and clearer in my head the more I blog about and talk about it, so this version may be a little clearer than
The Dow’s march onward and upward toward 30,000 continues without a pause. New all-time highs are notched practically every day. Despite Thursday’s 31-point pullback, the Dow is up over 15.5 percent year-to-date. What a remarkable time to be alive. The
The current housing scenario doesn’t seem all that rosy with housing data for the July-August period showing dismal growth. Of late, the industry has been dealing with a shortage in inventory which is raising prices in several parts of the
On Wednesday, we noted that according to his latest newsletter, Jim Grant is bearish on Ray Dalio. And Jim’s reasoning is pretty straightforward: Activities [like] tweeting, promoting his book, attacking the press have one thing in common: They are not investing. Yet here he is,
Cantor Fitzgerald analyst Louise Chen says she’s received calls today regarding concerns about Valeant Pharmaceuticals’ (VRX) financial controls. As reported last night by The Fly, Wells Fargo analyst David Maris expressed concern over Valeant’s controls after digging into the lawsuit
